A case of COVID-19 in a patient with pemphigus on azathioprine: Successful management with methylprednisolone
COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that first appeared in Wuhan, China. It is not just a respiratory disease but a multisystem disease. Risk factors for mortality and morbidity include advanced age, male gender, hypertension and immunosuppressive conditions. We present the case of COVID-19 that developed in a 31-year-old female patient who received azathioprine therapy with a diagnosis of pemphigus.
Authors
- Mustafa Atasoy (ORCID: https://orcid.org/0000-0003-1904-9878)
- Asuman Kilitçi (ORCID: https://orcid.org/0000-0002-5489-2222)
- Ömer Faruk Elmas (ORCID: https://orcid.org/0000-0002-5474-6508)
- Ümit Türsen (ORCID: https://orcid.org/0000-0002-5807-6759)
- Abdullah Demirbaş (ORCID: https://orcid.org/0000-0002-3419-9084)
Institutions
- Istanbul Memorial Hospital (TR)
- Mersin Üniversitesi (TR)
- Kocaeli Üniversitesi (TR)
- Düzce Üniversitesi (TR)
Publication Details
- Journal
- Journal of Bionic Memory
- Published
- 2024-11-26
- DOI
- https://doi.org/10.53545/jbm.2024.41
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00